Luke Sergott
Stock Analyst at Barclays
(1.01)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
NTRA Natera | Maintains: Overweight | 190 210 | 157.12 | 33.66% | 4 | Aug 8, 2025 | |
TXG 10x Genomics | Maintains: Overweight | 13 15 | 12.31 | 21.85% | 13 | Aug 8, 2025 | |
FTRE Fortrea Holdings | Maintains: Underweight | 5 6 | 6.41 | -6.4% | 11 | Aug 7, 2025 | |
EXAS Exact Sciences | Maintains: Overweight | 65 55 | 40.92 | 34.41% | 6 | Aug 7, 2025 | |
CRL Charles River | Maintains: Equal-Weight | 155 165 | 148.8 | 10.89% | 8 | Aug 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 46 43 | 30.8 | 39.61% | 5 | Aug 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 15 13 | 12.11 | 7.35% | 25 | Aug 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 85 90 | 94.79 | -5.05% | 19 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 90 | 79.21 | 13.62% | 1 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 155 180 | 159.85 | 12.61% | 20 | Jul 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 450 490 | 462.25 | 6% | 26 | Jul 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 300 450 | 449.72 | 0.06% | 2 | Jul 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 165 185 | 180.09 | 2.73% | 23 | Jul 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 2 | 1.25 | 20% | 5 | Jun 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 15 13 | 14.06 | -7.54% | 21 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 215 225 | 199.79 | 12.62% | 35 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 115 125 | 114.15 | 9.51% | 10 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 245 | 240.33 | 1.94% | 1 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 150 | 111.93 | 34.01% | 1 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 55 | 48.01 | 14.56% | 1 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 1325 | 1257.25 | 5.39% | 1 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 11 14 | 10.46 | 33.84% | 17 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 55 60 | 54.81 | 9.47% | 3 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 400 350 | 279.45 | 25.25% | 18 | Apr 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 45 | 27.63 | 62.87% | 17 | Apr 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 110 | 85.81 | 28.19% | 9 | Apr 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 47 63 | 63.48 | -0.76% | 16 | Jun 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 140 125 | 115.24 | 8.47% | 7 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 43 | 42.98 | 0.05% | 13 | May 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 29 25 | 17.63 | 41.8% | 3 | Dec 27, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 42 | 47.28 | -11.17% | 1 | Mar 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 22 21 | n/a | n/a | 1 | Apr 24, 2020 |